Chen Si, Kong Jinfeng, Feng Lei
Eye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Department of Ophthalmology, Jinshan Branch of Shanghai Sixth People's Hospital, Shanghai, China.
Front Med (Lausanne). 2022 Feb 23;9:807319. doi: 10.3389/fmed.2022.807319. eCollection 2022.
Macular edema is the most common cause of impaired vision due to uveitis. Although various medications are available, not all uveitis patients with macular edema are satisfied with the treatment results. Therefore, solving this gap becomes the utmost concern worldwide. This study attempted to use bibliometric analysis to compare the valuable information in the top 100 highly cited studies in the field of drug therapy for uveitic macular edema (UME) and then determine the research hot spots and trends in this field.
In this study, the Science Citation Index Expanded (SCIE) of Web of Science (WOS) was used to collect the top 100 most cited studies on UME and analyze the literature from different countries/regions, institutions, and journals. The visualization knowledge maps is generated by VOSviewer and Citespace software.
The top 100 highly cited studies are from 34 countries/regions. The United States has the largest number of publications, followed by the England, Spain and Germany. The top three institutions publishing highly cited literature are all from the England: University of London, University College London, and Moorfields Eye Hospital NHS Foundation Trust. is the most widely published journal with 14 papers. The total number of citations is 1,371, meaning that is the most authoritative journal in the field of UME drug therapy. The top two articles with the most cited times are from the United States, accounting for 36.5% of the total cited times of the top 10 articles. Keywords were divided into three clusters: the corticosteroid administration pathway, biological agents, and clinical trials. Uveitis, cystoid macular edema, efficacy, dexamethasone, and triamcinolone acetonide appeared more frequently in keywords. Researches on local and long-acting drug has gradually becoming the hot spots and trends.
This study concludes that bibliometric analysis can intuitively and quickly obtain the frontiers and hot spots of research in the field of UME drug therapy. Corticosteroid administration, biological agents, and clinical trials are considered the potential focus of future research.
黄斑水肿是葡萄膜炎导致视力受损的最常见原因。尽管有多种药物可用,但并非所有患有黄斑水肿的葡萄膜炎患者都对治疗结果满意。因此,解决这一差距成为全球最为关注的问题。本研究试图运用文献计量分析来比较葡萄膜炎性黄斑水肿(UME)药物治疗领域被引频次最高的前100项研究中的有价值信息,进而确定该领域的研究热点和趋势。
在本研究中,使用科学网(WOS)的科学引文索引扩展版(SCIE)来收集关于UME被引频次最高的前100项研究,并分析来自不同国家/地区、机构和期刊的文献。通过VOSviewer和Citespace软件生成可视化知识图谱。
被引频次最高的前100项研究来自34个国家/地区。美国的出版物数量最多,其次是英国、西班牙和德国。发表高被引文献的前三大机构均来自英国:伦敦大学、伦敦大学学院和摩尔菲尔德眼科医院国民保健服务信托基金。《》是发表论文最多的期刊,有14篇论文。总被引频次为1371次,这意味着《》是UME药物治疗领域最具权威性的期刊。被引次数最多的前两篇文章来自美国,占前10篇文章总被引次数的36.5%。关键词分为三个聚类:皮质类固醇给药途径、生物制剂和临床试验。葡萄膜炎、黄斑囊样水肿、疗效、地塞米松和曲安奈德在关键词中出现的频率更高。对局部和长效药物的研究逐渐成为热点和趋势。
本研究得出结论,文献计量分析可以直观、快速地获取UME药物治疗领域的研究前沿和热点。皮质类固醇给药、生物制剂和临床试验被认为是未来研究的潜在重点。